The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The Sensory Symptoms of Diabetic Polyneuropathy Are Improved With α-Lipoic Acid
Abstract
OBJECTIVE— Because α-lipoic acid (ALA), a potent antioxidant, prevents or improves nerve conduction attributes, endoneurial blood flow, and nerve (Na(+) K(+) ATPase activity in experimental diabetes and in humans and may improve positive neuropathic sensory symptoms, in this report we further assess the safety and efficacy of ALA on the Total Symptom Score (TSS), a measure of positive neuropathic sensory symptoms. RESEARCH DESIGN AND METHODS— Metabolically stable diabetic patients with symptomatic (stage 2) diabetic sensorimotor polyneuropathy (DSPN) were randomized to a parallel, double-blind study of ALA (600 mg) (n = 60) or placebo (n = 60) infused daily intravenously for 5 days/week for 14 treatments. The primary end point was change of the sum score of daily assessments of severity and duration of TSS. Secondary end points were sum scores of neuropathy signs (NIS), symptoms (NSC), attributes of nerve conduction, quantitative sensation tests (QSTs), and an autonomic test. RESULTS— At randomization, the groups were not significantly different by the criteria of metabolic control or neuropathic end points. After 14 treatments, the TSS of the ALA group had improved from baseline by an average of 5.7 points and the placebo group by an average of 1.8 points (P < 0.001). Statistically significant improvement from baseline of the ALA, as compared with the placebo group, was also found for each item of the TSS (lancinating and burning pain, asleep numbness and prickling), NIS, one attribute of nerve conduction, and global assessment of efficacy. CONCLUSIONS— Intravenous racemic ALA, a potent antioxidant, rapidly and to a significant and meaningful degree, improved such positive neuropathic sensory symptoms as pain and several other neuropathic end points. This improvement of symptoms was attributed to improved nerve pathophysiology, not to increased nerve fiber degeneration. Because of its safety profile and its effect on positive neuropathic sensory symptoms and other neuropathic end points, this drug appears to be a useful ancillary treatment for the symptoms of diabetic polyneuropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Alpha-lipoic acid as a biological antioxidant
Packer, L., Witt, E. H., & Tritschler, H. J. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(95)00017-r · Cited by 1,979
Self-citationFeldman, E. L., Callaghan, B. C., Pop-Busui, R., Zochodne, D. W., Wright, D. E., Bennett, D. L., Bril, V., Russell, J. W., & Viswanathan, V. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0092-1 · Cited by 1,697
Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood
Max, M. B., Culnane, M., Schafer, S. C., Gracely, R. H., Walther, D. J., Smoller, B., & Dubner, R. (1987) · Neurology · doi:10.1212/wnl.37.4.589 · Cited by 702
(1997) · PubMed · Cited by 581
Reactive oxygen species‐induced molecular damage and its application in pathology
Toyokuni, S. (1999) · Pathology International · doi:10.1046/j.1440-1827.1999.00829.x · Cited by 552
Ziegler, D., Hanefeld, M., Ruhnau, K. J., Mei\ner, H. P., Lobisch, M., Sch�tte, K., Gries, F. A., & The ALADIN Study Group (1995) · Diabetologia · doi:10.1007/bf00400603 · Cited by 525
Self-citationZiegler, D., Hanefeld, M., Ruhnau, K. J., Hasche, H., Lobisch, M., Schütte, K., Kerum, G., & Malessa, R. (1999) · Diabetes Care · doi:10.2337/diacare.22.8.1296 · Cited by 432
Self-citationNagamatsu, M., Nickander, K. K., Schmelzer, J. D., Raya, A., Wittrock, D. A., Tritschler, H., & Low, P. A. (1995) · Diabetes Care · doi:10.2337/diacare.18.8.1160 · Cited by 378
Self-citationThe DCCT Research Group (1986) · Diabetes · doi:10.2337/diab.35.5.530 · Cited by 331
Dyck, P. J., Davies, J. L., Wilson, D. M., Service, F. J., Melton, L. J., & O'Brien, P. C. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1479 · Cited by 328
Self-citationPathologic Alterations in the Diabetic Neuropathies of Humans: A Review
Dyck, P. J., & Giannini, C. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199612000-00001 · Cited by 295
Self-citationMalik, R. A., Williamson, S., Abbott, C., Carrington, A. L., Iqbal, J., Schady, W., & Boulton, A. J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02478-7 · Cited by 284
Ziegler, D., Schatz, H., Conrad, F., Gries, F. A., Ulrich, H., The DEKAN Study Group, & Reichel, G. (1997) · Diabetes Care · doi:10.2337/diacare.20.3.369 · Cited by 281
Self-citationNerve blood flow in early experimental diabetes in rats: relation to conduction deficits
Cameron, N. E., Cotter, M. A., & Low, P. A. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.261.1.e1 · Cited by 278
Self-citationLeinonen, J., Lehtimäki, T., Toyokuni, S., Okada, K., Tanaka, T., Hiai, H., Ochi, H., Laippala, P., Rantalaiho, V., Wirta, O., et al. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01273-8 · Cited by 262
Ziegler, D., Reljanovic, M., Mehnert, H., & Gries, F. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1212132 · Cited by 220
Self-citationOxidative DNA damage in diabetes mellitus: its association with diabetic complications
Hinokio, Y., Suzuki, S., Hirai, M., Chiba, M., Hirai, A., & Toyota, T. (1999) · Diabetologia · doi:10.1007/s001250051258 · Cited by 208
Cameron, N. E., Cotter, M. A., & Maxfield, E. K. (1993) · Diabetologia · doi:10.1007/bf00400231 · Cited by 181
Oxygen Free Radical Effects in Sciatic Nerve in Experimental Diabetes
Low, P. A., & Nickander, K. K. (1991) · Diabetes · doi:10.2337/diab.40.7.873 · Cited by 169
Self-citationInteractions among Antioxidants in Health and Disease: Vitamin E and Its Redox Cycle
Packer, L. (1992) · Experimental Biology and Medicine · doi:10.3181/00379727-200-43433 · Cited by 164
α-Lipoic Acid in the Treatment of Diabetic Peripheral and Cardiac Autonomic Neuropathy
Ziegler, D., & Gries, F. A. (1997) · Diabetes · doi:10.2337/diab.46.2.s62 · Cited by 163
Self-citationYounger, D. S., Rosoklija, G. B., Hays, A. P., Trojaborg, W., & Latov, N. (1996) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199606)19:6<722::aid-mus6>3.0.co;2-c · Cited by 143
Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy
Service, F. J., Rizza, R. A., Daube, J. R., O’Brien, P. C., & Dyck, P. J. B. (1985) · Diabetologia · doi:10.1007/bf00265018 · Cited by 141
Self-citationBravenboer, B., Kappelle, A. C., Hamers, F. P. T., van Buren, T., Erkelens, D. W., & Gispen, W. H. (1992) · Diabetologia · doi:10.1007/bf00399926 · Cited by 129
JAMAL, G. A., & Carmichael, H. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01397.x · Cited by 122
Morphometry of Dorsal Root Ganglion in Chronic Experimental Diabetic Neuropathy
Kishi, M., Tanabe, J., Schmelzer, J. D., & Low, P. A. (2002) · Diabetes · doi:10.2337/diabetes.51.3.819 · Cited by 115
Self-citationAmthor, K.-F., Dahl‐Jørgensen, K., Tj, B., Heier, M., Sandvik, L., Aagen�s, �., & Hanssen, K. F. (1994) · Diabetologia · doi:10.1007/bf00403376 · Cited by 110
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials
Apfel, S. C., Asbury, A. K., Bril, V., Burns, T. M., Campbell, J. N., Chalk, C., Dyck, P. J., Dyck, P. J., Feldman, E. L., Fields, H. L., et al. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00584-6 · Cited by 106
Self-citationNickander, K. K., Schmelzer, J. D., Rohwer, D. A., & Low, P. A. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90088-4 · Cited by 84
Self-citationRedox regulation of NF-kappa B DNA binding activity by dihydrolipoate.
Suzuki, Y., Mizuno, M., Tritschler, H., & Packer, L. (1995) · PubMed · Cited by 45
Self-citationAcetyl-L-carnitine for symptomatic diabetic neuropathy
Quatraro, A., Roca, P. B., Donzella, C., Acampora, R., Marfella, R., & Giugliano, D. (1995) · Diabetologia · doi:10.1007/bf02369363 · Cited by 43
Chemie und Biochemie der α‐Liponsäure
Schmidt, U., Grafen, P., & Goedde, H. W. (1965) · Angewandte Chemie · doi:10.1002/ange.19650772004 · Cited by 13
Pharmacologic approaches to neuropathic pain
Lipman, A. G. (1997) · Current Review of Pain · doi:10.1007/bf02938298 · Cited by 12
Cited by
Gertz, M. A., Comenzo, R., Falk, R. H., Fermand, J. P., Hazenberg, B. P., Hawkins, P. N., Merlini, G., Moreau, P., Ronco, P., Sanchorawala, V., et al. (2005) · American Journal of Hematology · doi:10.1002/ajh.20381 · Cited by 1,428
Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice
Johansen, J. S., Harris, A. K., Rychly, D. J., & Ergul, A. (2005) · Cardiovascular Diabetology · doi:10.1186/1475-2840-4-5 · Cited by 1,003
Oxidative Stress in the Pathogenesis of Diabetic Neuropathy
Vincent, A. M., Russell, J. W., Low, P., & Feldman, E. L. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0019 · Cited by 982
Self-citationAlpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential
Shay, K. P., Moreau, R. F., Smith, E. J., Smith, A. R., & Hagen, T. M. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.07.026 · Cited by 976
Boulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913
Metadata
- Authors
- The SYDNEY Trial Authors, F. T. S. T. S. G., Ametov, A. S., Barinov, A., Dyck, P. J., Hermann, R., Kozlova, N., Litchy, W. J., Low, P. A., Nehrdich, D., Novosadova, M., O’Brien, P. C., Reljanovic, M., Samigullin, R., Schuette, K., Strokov, I., Tritschler, H. J., Wessel, K., Yakhno, N., & Ziegler, D.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2003-03-01
- Volume
- 26
- Issue
- 3
- Pages
- 770-776
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2135500154
- Cited by
- 359
- References
- 34
- FWCI
- 13.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.